X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (3126) 3126
Book Review (560) 560
Publication (157) 157
Newsletter (103) 103
Book Chapter (10) 10
Magazine Article (7) 7
Conference Proceeding (5) 5
Newspaper Article (3) 3
Dissertation (1) 1
Paper (1) 1
Reference (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (2606) 2606
humans (2298) 2298
synovitis (1579) 1579
male (1475) 1475
female (1410) 1410
rheumatology (1250) 1250
middle aged (1061) 1061
adult (915) 915
rheumatoid arthritis (913) 913
synovitis - drug therapy (799) 799
arthritis (771) 771
aged (748) 748
arthritis, rheumatoid - drug therapy (576) 576
treatment outcome (553) 553
inflammation (532) 532
animals (522) 522
synovitis - pathology (479) 479
abridged index medicus (404) 404
rheumatoid-arthritis (394) 394
antirheumatic agents - therapeutic use (392) 392
magnetic resonance imaging (387) 387
synovitis - etiology (339) 339
ultrasonography (337) 337
osteoarthritis (334) 334
care and treatment (330) 330
synovitis - diagnosis (315) 315
severity of illness index (313) 313
arthritis, rheumatoid - diagnostic imaging (311) 311
synovitis - diagnostic imaging (303) 303
adolescent (295) 295
rheumatoid factor (289) 289
knee (279) 279
ultrasound (277) 277
injections, intra-articular (273) 273
diagnosis (265) 265
arthritis, rheumatoid - pathology (264) 264
research (263) 263
disease (260) 260
pain (260) 260
medicine & public health (252) 252
synovial membrane - pathology (250) 250
orthopedics (248) 248
child (247) 247
patients (246) 246
radiography (243) 243
follow-up studies (211) 211
arthritis, rheumatoid - diagnosis (205) 205
surgery (193) 193
therapy (192) 192
methotrexate (190) 190
diagnosis, differential (188) 188
synovitis - complications (188) 188
immunology (181) 181
joint diseases (181) 181
arthritis, rheumatoid - complications (179) 179
disease progression (177) 177
disease-activity (177) 177
analysis (176) 176
arthritis, rheumatoid - immunology (175) 175
time factors (171) 171
synovitis - immunology (169) 169
aged, 80 and over (168) 168
remission (164) 164
ultrasonic imaging (161) 161
usage (161) 161
cytokines (159) 159
young adult (158) 158
prognosis (156) 156
drug therapy (154) 154
cartilage (151) 151
mice (149) 149
progression (147) 147
health aspects (146) 146
prospective studies (146) 146
drug therapy, combination (145) 145
retrospective studies (143) 143
anti-inflammatory agents, non-steroidal - therapeutic use (139) 139
synovitis - metabolism (139) 139
wrist (139) 139
synovitis - physiopathology (138) 138
medical research (137) 137
research article (137) 137
radiology, nuclear medicine & medical imaging (134) 134
joints (131) 131
double-blind (130) 130
studies (130) 130
anti-inflammatory agents - therapeutic use (129) 129
child, preschool (128) 128
magnetic resonance imaging - methods (128) 128
arthritis - drug therapy (126) 126
expression (126) 126
disease models, animal (125) 125
musculoskeletal diseases (125) 125
children (124) 124
chronic disease (121) 121
risk factors (121) 121
arthroscopy (117) 117
knee joint (116) 116
veterinary sciences (116) 116
medicine, general & internal (114) 114
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (3048) 3048
German (65) 65
French (38) 38
Russian (29) 29
Spanish (16) 16
Italian (15) 15
Japanese (14) 14
Chinese (6) 6
Danish (4) 4
Hungarian (3) 3
Polish (3) 3
Czech (2) 2
Croatian (1) 1
Dutch (1) 1
Finnish (1) 1
Hebrew (1) 1
Korean (1) 1
Norwegian (1) 1
Persian (1) 1
Portuguese (1) 1
Romanian (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet Oncology, The, ISSN 1470-2045, 2015, Volume 16, Issue 8, pp. 949 - 956
Summary Background Diffuse-type tenosynovial giant cell tumour (dt-GCT) of the soft tissue (alternatively known as pigmented villonodular synovitis), an orphan... 
Hematology, Oncology and Palliative Medicine | PIGMENTED VILLONODULAR SYNOVITIS | DIAGNOSIS | THERAPY | MANAGEMENT | ONCOLOGY | PERIORBITAL EDEMA SECONDARY | MACROPHAGES | RECEPTOR | LEUKEMIA | ARTHRITIS | IMATINIB MESYLATE | Receptor, Macrophage Colony-Stimulating Factor - antagonists & inhibitors | Receptor, Macrophage Colony-Stimulating Factor - immunology | Giant Cell Tumors - immunology | Humans | Middle Aged | Antibodies, Monoclonal - adverse effects | Giant Cell Tumors - pathology | Soft Tissue Neoplasms - drug therapy | Male | Antineoplastic Agents - administration & dosage | Giant Cell Tumors - metabolism | Receptor, Macrophage Colony-Stimulating Factor - metabolism | Synovitis, Pigmented Villonodular - drug therapy | Synovitis, Pigmented Villonodular - pathology | Soft Tissue Neoplasms - immunology | Young Adult | Time Factors | Antineoplastic Agents - adverse effects | Aged, 80 and over | Adult | Female | Drug Administration Schedule | Soft Tissue Neoplasms - metabolism | Synovitis, Pigmented Villonodular - metabolism | Treatment Outcome | Synovitis, Pigmented Villonodular - immunology | Giant Cell Tumors - drug therapy | Signal Transduction - drug effects | Antibodies, Monoclonal - administration & dosage | Adolescent | Soft Tissue Neoplasms - pathology | Aged | Infusions, Intravenous | Monoclonal antibodies | Macrophage colony stimulating factor | Tumors | Index Medicus
Journal Article
JAMA, ISSN 0098-7484, 05/2017, Volume 317, Issue 19, pp. 1967 - 1975
IMPORTANCE: Synovitis is common and is associated with progression of structural characteristics of knee osteoarthritis. Intra-articular corticosteroids could... 
UNITED-STATES | MEDICINE, GENERAL & INTERNAL | METAANALYSIS | ULTRASOUND | DISEASE | CORTICOSTEROID INJECTIONS | ARTHRITIS | JOINT | PROGRESSION | LESIONS | SYNOVITIS | Sodium Chloride - adverse effects | Glucocorticoids - administration & dosage | Outcome Assessment (Health Care) | Cartilage - pathology | Synovitis - complications | Arthralgia - blood | Glycated Hemoglobin A - metabolism | Humans | Middle Aged | Arthralgia - diagnostic imaging | Male | Cartilage - drug effects | Synovitis - diagnostic imaging | Anti-Inflammatory Agents - adverse effects | Osteoarthritis, Knee - blood | Anti-Inflammatory Agents - administration & dosage | Female | Glucocorticoids - adverse effects | Triamcinolone Acetonide - administration & dosage | Synovitis - drug therapy | Double-Blind Method | Drug Administration Schedule | Linear Models | Sodium Chloride - administration & dosage | Triamcinolone Acetonide - adverse effects | Osteoarthritis, Knee - diagnostic imaging | Magnetic Resonance Imaging | Sample Size | Injections, Intra-Articular | Arthralgia - drug therapy | Cartilage - diagnostic imaging | Osteoarthritis, Knee - drug therapy | Knee | Clinical trials | Arthritis | Knee (anatomy) | Patients | Cartilage | Randomization | Pain | Hemoglobin | Biocompatibility | Osteoarthritis | Triamcinolone acetonide | Cartilage diseases | Index Medicus | Abridged Index Medicus | Original Investigation | Research
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 07/2015, Volume 373, Issue 5, pp. 428 - 437
Journal Article
International Journal of Hyperthermia, ISSN 0265-6736, 08/2016, Volume 32, Issue 6, pp. 595 - 599
Background: Isolated limb perfusion (ILP) is an established and effective treatment for advanced melanoma and soft tissue sarcomas of the extremities with a... 
isolated limb perfusion | Advanced status | local control | rare tumours | SOFT-TISSUE SARCOMAS | COMPLETE REMISSION | EXTREMITIES | NECROSIS-FACTOR-ALPHA | T-CELL LYMPHOMA | MALIGNANT-MELANOMA | REGIONAL PERFUSION | ONCOLOGY | TNF-ALPHA | MELPHALAN | CARCINOMA | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | Humans | Lymphoma, B-Cell - therapy | Rare Diseases - drug therapy | Carcinoma, Merkel Cell - therapy | Giant Cell Tumors - therapy | Melphalan - therapeutic use | Synovitis, Pigmented Villonodular - therapy | Carcinoma, Merkel Cell - drug therapy | Synovitis, Pigmented Villonodular - drug therapy | Fibromatosis, Aggressive - therapy | Hyperthermia, Induced | Adenomatous Polyposis Coli - therapy | Extremities | Fibromatosis, Aggressive - drug therapy | Lymphoma, B-Cell - drug therapy | Abdominal Neoplasms - therapy | Abdominal Neoplasms - drug therapy | Carcinoma, Squamous Cell - therapy | Antineoplastic Agents, Alkylating - therapeutic use | Tumor Necrosis Factor-alpha - therapeutic use | Carcinoma, Squamous Cell - drug therapy | Giant Cell Tumors - drug therapy | Rare Diseases - therapy | Perfusion | Adenomatous Polyposis Coli - drug therapy | Chemotherapy, Cancer, Regional Perfusion | Index Medicus | necrosis-factor-alpha | melphalan | Oncology | t-cell lymphoma | Nuclear Medicine & Medical Imaging | Klinisk medicin | tnf-alpha | extremities | Clinical Medicine | carcinoma | complete remission | Radiology | soft-tissue sarcomas | malignant-melanoma | regional perfusion
Journal Article
Annals of the Rheumatic Diseases, ISSN 0003-4967, 09/2010, Volume 69, Issue 9, pp. 1636 - 1642
Objectives Combination therapy with methotrexate (MTX) and tumour necrosis factor (TNF) blockade has increased remission rates in patients with rheumatoid... 
CLINICAL REMISSION | CONTROLLED-TRIAL | EARLY RHEUMATOID-ARTHRITIS | ACTIVATED T-CELLS | DOUBLE-BLIND | DIFFERENT TREATMENT STRATEGIES | DELAYED TREATMENT | RHEUMATOLOGY | ADALIMUMAB PLUS METHOTREXATE | COMBINATION | DISEASE-ACTIVITY | Follow-Up Studies | Antirheumatic Agents - administration & dosage | Humans | Middle Aged | Male | Methotrexate - therapeutic use | Arthritis, Rheumatoid - complications | Synovitis - diagnostic imaging | T-Lymphocytes, Regulatory - immunology | Arthritis, Rheumatoid - diagnostic imaging | CD4-Positive T-Lymphocytes - immunology | Young Adult | Arthritis, Rheumatoid - drug therapy | Synovitis - etiology | Ultrasonography | Adult | Female | Drug Therapy, Combination | Antirheumatic Agents - therapeutic use | Drug Administration Schedule | Immunophenotyping | Treatment Outcome | Remission Induction | Aged | Arthritis, Rheumatoid - immunology | Tumor Necrosis Factor-alpha - antagonists & inhibitors | Complications and side effects | Antirheumatic agents | Rheumatoid arthritis | Patient outcomes | Dosage and administration | Research | Drug therapy, Combination | Drug therapy | Methotrexate | Studies | Ultrasonic imaging | Immunology | Statistical analysis | Lymphocytes | Immunotherapy | TNF inhibitors | Tumor necrosis factor-TNF | Inflammation | Multivariate analysis | Drug dosages | Index Medicus
Journal Article
Arthritis Research and Therapy, ISSN 1478-6354, 09/2012, Volume 14, Issue 5, pp. R198 - R198
Journal Article
Annals of the Rheumatic Diseases, ISSN 0003-4967, 06/2016, Volume 75, Issue 6, pp. 1024 - 1033
ObjectivesTo explore the effects of tofacitinib—an oral Janus kinase inhibitor for the treatment of rheumatoid arthritis (RA)—with or without methotrexate... 
JAK INHIBITOR | MODIFYING ANTIRHEUMATIC DRUGS | SMALLEST DETECTABLE DIFFERENCE | INADEQUATE RESPONSE | JOINT DAMAGE | DOUBLE-BLIND | STRUCTURAL DAMAGE | PLACEBO-CONTROLLED TRIAL | RHEUMATOLOGY | PROGRESSION | CP-690,550 | Bone Marrow Diseases - etiology | Wrist Joint - diagnostic imaging | Antirheumatic Agents - administration & dosage | Humans | Middle Aged | Male | Arthritis, Rheumatoid - complications | Synovitis - diagnostic imaging | Arthritis, Rheumatoid - diagnostic imaging | Edema - diagnostic imaging | Bone Marrow Diseases - drug therapy | Arthritis, Rheumatoid - drug therapy | Pyrroles - administration & dosage | Synovitis - etiology | Adult | Female | Drug Therapy, Combination | Bone Marrow - drug effects | Synovitis - drug therapy | Piperidines - administration & dosage | Double-Blind Method | Pyrimidines - administration & dosage | Treatment Outcome | Edema - drug therapy | Hand - diagnostic imaging | Disease Progression | Edema - etiology | Magnetic Resonance Imaging | Bone Density - drug effects | Bone Marrow Diseases - diagnostic imaging | Methotrexate - administration & dosage | Care and treatment | Usage | Tofacitinib | Rheumatoid arthritis | Clinical trials | Dosage and administration | Methotrexate | Index Medicus | Clinical and Epidemiological Research | DMARDs (synthetic) | Rheumatoid Arthritis | Inflammation | 1506
Journal Article
Journal Article
Journal Article
Rheumatology (Oxford, England), ISSN 1462-0324, 06/2015, Volume 54, Issue 6, pp. 1008 - 1016
Journal Article